The combination of EGFR gain and PTEN loss (+ EGFR/− PTEN) was detected in 6 IDH-wild-type astrocytomas (14.3%), comprising 3 DAs (16.7%) and 3 AAs (12.5%), showing no significant difference. This evidence concerns the gene IDH2 and astrocytoma (excluding glioblastoma).